rhein has been researched along with Invasiveness, Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Luo, B; Pi, R; Wen, S | 1 |
| Bian, Y; Cao, H; Dong, S; Li, J; Liu, P; Sun, L; Sun, M; Sun, R; Wu, C; Xue, J; Zhou, H | 1 |
| Chen, Y; Li, D; Peng, F; Tang, M; Zhong, Y; Zhou, G | 1 |
| Chen, SS; Chung, JG; Lin, ML; Lu, YC; Yang, CY | 1 |
| Chen, YY; Chiang, SY; Chung, JG; Lai, TY; Liao, CL; Lin, JG; Ma, YS; Weng, SW | 1 |
| Bwambok, DK; Fakayode, SO; Fernand, VE; Losso, JN; Lowry, M; Truax, RE; Villar, EE; Warner, IM | 1 |
1 review(s) available for rhein and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Research Progress on the Antitumor Effects of Rhein: Literature Review.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Proliferation; Humans; Lipid Metabolism; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phosphorylation | 2017 |
5 other study(ies) available for rhein and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
Topics: Anthraquinones; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; Glioma; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Immediate-Early Proteins; Neoplasm Invasiveness; Protein Serine-Threonine Kinases; Vorinostat | 2020 |
Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Topics: Aminoquinolines; Anthraquinones; Cell Line, Tumor; Cell Movement; Female; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Matrix Metalloproteinases, Secreted; Neoplasm Invasiveness; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphorylation; Pyrimidines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor AP-1 | 2017 |
Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor.
Topics: Anthraquinones; Cell Movement; Down-Regulation; Enzyme Inhibitors; GRB2 Adaptor Protein; Humans; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase Kinases; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; NF-kappa B; ras Proteins; Son of Sevenless Proteins; Vascular Endothelial Growth Factor A | 2009 |
Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.
Topics: Aloe; Anthraquinones; Cell Line, Tumor; Cell Movement; Drug Screening Assays, Antitumor; Emodin; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; RNA, Messenger; Tongue Neoplasms; Urokinase-Type Plasminogen Activator | 2010 |
Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Topics: Angiogenesis Inhibitors; Anthraquinones; Anticarcinogenic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Female; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; NF-kappa B; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A | 2011 |